YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Avandia
Avandia Removed from HealthTrans Pharmacy, Prime Therapeutics Formularies Due to Heart Attack Risk
Dec 7, 2007 | Parker Waichman Alonso LLP
Avandia has taken another hit on the chin, as two large pharmacy benefit managers announced that they would be dropping the controversial diabetes...
Avandia Researchers Find Reason Behind Bone Fracture, Osteoporosis Side Effects
Dec 3, 2007 | Parker Waichman Alonso LLP
Avandia places patients at a high risk of bone fractures and osteoporosis by affecting the way bone cells are replenished in the body. While...
Avandia Heart Attack Controversy Results in Black Box Warning, but Critics Still Want Diabetes Drug Off the Market
Nov 29, 2007 | Parker Waichman Alonso LLP
Avandia, a drug used in the treatment of type 2 diabetes, has been at the center of controversy since being linked to an increased risk of heart...
Avandia Side Effects Prompt New Caution from American Diabetes Association
Nov 27, 2007 | Parker Waichman Alonso LLP
Risks associated with Avandia have led the American Diabetes Association to call on doctors to use more caution when prescribing oral medications to...
Avandia Reviewer Calls for Changes in FDA Drug Approval Process
Nov 27, 2007 | Parker Waichman Alonso LLP
The Avandia debacle has prompted a safety official from the Food & Drug Administration (FDA) to call for changes in the way diabetes medications...
Avandia Safety Scandal Won't Go Away, As Senators Seek to Question Former Glaxo Exec
Nov 23, 2007 | Parker Waichman Alonso LLP
The addition of a new Avandia black box warning about heart attack risk has done little to quell criticism over the way GlaxosmithKline, the...
GlaxoSmithKline Tried to Intimidate, Silence Avandia Critic Report Says
Nov 19, 2007 | Parker Waichman Alonso LLP
GlaxoSmithKline, the maker of Avandia, made a concerted effort to intimidate a prominent physician into keeping quiet about some of the controversial...
Avandia Controversy Won't Go Away with New Heart Attack Black Box Warning
Nov 15, 2007 | Parker Waichman Alonso LLP
Avandia is getting yet another break from the Food & Drug Administration (FDA). While the FDA did announce the addition of a long-awaited...
Avandia Black Box Heart Attack Warning Finally Approved
Nov 14, 2007 | Parker Waichman Alonso LLP
Avandia will finally bear a new black box warning about heart attack risks associated with the controversial diabetes drug, the Food & Drug...
Avandia Heart Attack Warning from FDA Imminent, As Glaxo CEO Says Avandia Sales Could Rebound
Nov 13, 2007 | Parker Waichman Alonso LLP
Avandia could soon bear a long-awaited black box warning about its potential to cause heart attacks, as media outlets are reporting that a Food &...
Avandia
